Crossmark

Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi

Crossref DOI link: https://doi.org/10.1186/s12936-016-1634-6

Published Online: 2016-11-29

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ravenhall, Matt http://orcid.org/0000-0002-7818-2348
Benavente, Ernest Diez

Mipando, Mwapatsa

Jensen, Anja T. R.

Sutherland, Colin J.

Roper, Cally

Sepúlveda, Nuno

Kwiatkowski, Dominic P.

Montgomery, Jacqui

Phiri, Kamija S.

Terlouw, Anja

Craig, Alister

Campino, Susana

Ocholla, Harold

Clark, Taane G.
Funding

Funding for this research was provided by:

Biotechnology and Biological Sciences Research Council (BB/J014567/1)

Wellcome Trust (WT084289MA, 080964, 077012/Z/05/Z, 090770/Z/09/Z)

Medical Research Council (MR/K000551/1, MR/M01360X/1, MR/N010469/1, MC_PC_15103, MR/M01360X/1, MC_PC_15103)